Acuren Corporation (TIC)
NYSEAMERICAN: TIC · Real-Time Price · USD
10.53
+0.17 (1.64%)
At close: May 9, 2025, 4:00 PM
10.53
0.00 (0.00%)
After-hours: May 9, 2025, 8:00 PM EDT
Acuren Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Acuren stock has a target of 13, which predicts an increase of 23.46% from the current stock price of 10.53.
Analyst Consensus: Hold
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Acuren is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Apr '25 | May '25 |
---|---|---|
Strong Buy | 0 | 0 |
Buy | 0 | 0 |
Hold | 1 | 1 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Initiates $13 | Hold | Initiates | $13 | +23.46% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
1.15B
from 1.10B
Increased by 4.52%
Revenue Next Year
1.21B
from 1.15B
Increased by 5.23%
EPS This Year
0.44
from -2.22
EPS Next Year
0.54
from 0.44
Increased by 22.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.2B | 1.3B | 1.3B |
Avg | 1.1B | 1.2B | 1.2B |
Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 8.2% | 9.7% | 6.4% |
Avg | 4.5% | 5.2% | 3.3% |
Low | -0.2% | -0.1% | -0.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.87 | 0.96 | 1.01 |
Avg | 0.44 | 0.54 | 0.98 |
Low | 0.03 | 0.14 | 0.94 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 117.9% | 88.2% |
Avg | - | 22.1% | 82.9% |
Low | - | -68.7% | 75.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.